- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Big Green Snowflakes
U.S. Pharmaceuticals & Biotech Big Green Snowflakes
Results
1269
0 new
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
1,269 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRK | US$97.44 | -1.1% | -4.2% | US$244.2b | US$131.08 | PE20.3x | E15.6% | 3.2% | ||
NBIX | US$123.29 | -1.8% | 11.1% | US$12.1b | US$163.46 | PE32.3x | E29.6% | n/a | ||
CPRX | US$21.15 | -7.2% | 52.6% | US$2.6b | US$32.25 | PE17.7x | E17.5% | n/a | ||
GILD | US$88.63 | -4.3% | 17.1% | US$109.2b | US$96.92 | PE875.7x | E40.9% | 3.5% | ||
BSEM | US$12.04 | -48.5% | 301.2% | US$211.1m | US$32.50 | PE12.6x | E33.8% | n/a | ||
HALO | US$45.76 | -21.9% | 14.1% | US$5.7b | US$62.44 | PE14.8x | E21.1% | n/a | ||
CORT | US$56.09 | -0.6% | 121.3% | US$5.7b | US$74.90 | PE41.8x | E41.0% | n/a | ||
MDXG | US$9.06 | 21.3% | 19.7% | US$1.4b | US$13.00 | PE16.8x | E-1.9% | n/a | ||
PBYI | US$2.84 | -4.4% | -31.4% | US$134.5m | US$4.33 | PE6x | E-45.4% | n/a | ||
JNJ | US$153.11 | -0.08% | 1.5% | US$368.4b | US$174.89 | PE25x | E10.6% | 3.2% | ||
RPRX | US$26.22 | 1.4% | -3.5% | US$15.3b | US$41.53 | PE10.2x | E6.3% | 3.2% | ||
ADMA | US$21.37 | -0.5% | 441.0% | US$4.9b | US$23.45 | PE74.1x | E30.5% | n/a | ||
ACAD | US$16.27 | -7.5% | -26.0% | US$2.7b | US$25.11 | PE21.1x | E28.4% | n/a | ||
LGND | US$111.56 | -8.6% | 87.5% | US$2.1b | US$140.25 | PE46.6x | E35.5% | n/a | ||
HRMY | US$32.79 | -3.1% | 15.1% | US$1.9b | US$47.11 | PE15.3x | E32.8% | n/a | ||
ZYNE | US$1.30 | 4.0% | 96.1% | US$65.6m | US$1.26 | PB2.3x | E67.2% | n/a | ||
AGIO | US$54.62 | -6.8% | 148.7% | US$3.1b | US$53.88 | PE4.6x | E-56.7% | n/a | ||
PBSV | US$0.48 | -9.0% | -43.5% | US$11.5m | US$1.65 | PS1x | S53.3% | 46.9% | ||
ABBV | US$167.76 | -1.5% | 21.2% | US$294.4b | US$204.74 | PE58.3x | E28.1% | 3.9% | ||
MEDP | US$326.09 | -9.9% | 17.8% | US$9.8b | US$349.32 | PE27.7x | E10.9% | n/a | ||
SRPT | US$110.86 | -1.4% | 32.3% | US$10.2b | US$189.86 | PE86.9x | E42.6% | n/a | ||
EXEL | US$34.65 | -1.5% | 61.2% | US$9.8b | US$31.83 | PE21.2x | E15.6% | n/a | ||
IVVD | US$0.77 | -13.7% | -48.8% | US$91.8m | US$6.51 | PS7.9x | E72.2% | n/a | ||
INCY | US$71.05 | -11.7% | 33.1% | US$13.6b | US$78.05 | PE421.4x | E46.3% | n/a |